相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING
Derek M. Shore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
In-Young Choi et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
Gemma L. Baillie et al.
MOLECULAR PHARMACOLOGY (2013)
The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein-Coupled Receptors
Celine Valant et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors
Mark Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum
Xiaowei Wang et al.
MOLECULAR PHARMACOLOGY (2011)
Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice
Courtney D. Netherland et al.
ATHEROSCLEROSIS (2010)
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes
Ryuichiro Murakami et al.
LIFE SCIENCES (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Pharmacological characterization of GPR55, a putative cannabinoid receptor
Haleli Sharir et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Maryam Rakhshandehroo et al.
PPAR RESEARCH (2010)
The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice
N. L. Cluny et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Characterizing Cannabinoid CB2 Receptor Ligands Using DiscoveRx PathHunter (TM) beta-Arrestin Assay
Debra Mcguinness et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
K. L. Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND
Celine Valant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Fibrates and future PPAR alpha agonists in the treatment of cardiovascular disease
Bart Staels et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
J. G. Horswill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoid activation of PPARα;: a novel neuroprotective mechanism
Y. Sun et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase
Yossi Dagon et al.
FASEB JOURNAL (2007)
Biochemistry and pharmacology of endovanilloids
Katarzyna Starowicz et al.
PHARMACOLOGY & THERAPEUTICS (2007)
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
Liliane Michalik et al.
PHARMACOLOGICAL REVIEWS (2006)
The pharmacology of cannabinoid receptors and their ligands: an overview
RG Pertwee
INTERNATIONAL JOURNAL OF OBESITY (2006)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto et al.
ENDOCRINE REVIEWS (2006)
In silico patent searching reveals a new cannabinoid receptor
D Baker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
Review article: endocannabinoids and their receptors in the enteric nervous system
M Duncan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
J Fu et al.
NATURE (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
